People channel feed – Endpoints News

People channel feed

Dan O’Day’s to-do list for Gilead: Recruit a Kite CEO, press the pedal on next-gen cell therapies and start buying stuff

7 years ago

Terry Rosen is looking to leave the thundering herd and blaze a new trail in PD-1 R&D

7 years ago

Microbiome player uBiome puts founders on leave, interim CEO promises to assist in federal probe

7 years ago

Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics

7 years ago

173 to 1: Bristol-Myers chief Caforio picked up a $19.4M compensation deal after leading the charge for $74B Celgene buyout

7 years ago

Gilead loses yet another executive as CFO Washington joins exodus, jumping to Alphabet board

7 years ago

Share price blitzed, analysts in an uproar after lead PhIII drug implodes — and Biogen unveils a $2.5M raise for the CEO

7 years ago

Analyst pens a barbed note to Biogen: Shed caution, dump Alzheimer’s and retool at the top — go bold

7 years ago

Roiled by C-suite turmoil and a CRL, Immunomedics salutes CMO Rob Iannone as he makes a quick exit

7 years ago

After promising M&A and buybacks to revive long-term prospects, Biogen refreshes board with three appointments to enthuse investors

7 years ago

Fired for code of conduct violations, Ian Smith still grabbed a multimillion-dollar stock package at Vertex — but the cash bonus was axed

7 years ago

Len Schleifer and George Yancopoulos once again land in the top ranks of the highest paid execs in biopharma

7 years ago

‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp

7 years ago

Martin Shkreli gets a transfer to Brooklyn federal prison in wake of his latest rule-breaking escapades behind bars

7 years ago

Good year, bad year? Two biotech CEOs hit pay dirt in 2018 as compensation packages swell

7 years ago

Novartis CEO Narasimhan raids GlaxoSmithKline offices for his new Sandoz chief

7 years ago

‘Chief bluebird’ Nick Leschly nails a rich $24M compensation bounty as biotech packages soar

7 years ago

What’s it take to recruit a top drug development exec out of Gilead? Stock options help, a lot

7 years ago

Seattle Genetics CEO Clay Siegall's comp package soars to $18.1M, rivaling Big Pharma chiefs

7 years ago

Jeff Aronin's startup incubator scoops ex-Alkermes exec Jim Robinson for new president/COO role

7 years ago

France's Sanofi contributes €10M to the restoration of Notre Dame

7 years ago

'Patients are not a company's resource': FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer

7 years ago

Ned Sharpless is not playing with the FDA’s gold standard — any more than Scott Gottlieb did

7 years ago

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation

7 years ago

First page Previous page 79 80 818283 84 85 Next page Last page